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Stephen T. Warren
Good afternoon. My name is Steve Warren, and I am
honored, as the 58th president of the American Society
of Human Genetics, to address you today. At least two of
my predecessors, Arno Motulsky and Ron Worton, began
their address by stating that a presidential address to the
Society is a difficult task. I am sure this feeling was shared
by most other past presidents and, most certainly, by the
current one. As this date approached, I found myself doing
what many of my predecessors had done, namely review-
ing the prior presidential addresses. I was heartened to
learn that almost half of the prior presidents discussed
their research, including the delivery, over 50 years ago,
of a 65-page treatise by our first president, H. J. Muller,
on “Our Load of Mutations.” Do not worry, I have only
prepared 50 pages on fragile X syndrome…. No, all our
recent presidents have discussed the field of human ge-
netics, the state of our Society, and its past accomplish-
ments and future goals. While presenting the detailed data
on the health of our Society is appealing, as it lends itself
easily to PowerPoint slides, I choose instead to discuss the
role of our members in society and in our professional
society. The first topic I would like to discuss is our inter-
action, as ASHG members, with society in general, spe-
cifically involving legislation and education. I would then
like to discuss a few aspects of our society and end with
a few personal comments about this annual meeting. But
first, I would like to say a few words about this great city
we find ourselves in this afternoon.
New Orleans
I am delighted that we, as a Society, maintained our plan
to hold our annual meeting here in New Orleans, despite
the devastation of Hurricane Katrina, and to stand with
the people of this great American city. I am grateful also
to each of you for attending. Our most recent estimate of
attendance approaches 3,500 attendees, which compares
favorably with our projections. I am very grateful to the
ASHG staff, who worked hard to accommodate the revised
dates and to ensure, during the past several months, that
the meeting would flow smoothly. The board of directors
have been resolute in their view that this meeting should
be held here in New Orleans and that our presence would
be one small but important act to help rebuild this city.
This is something we as a Society should be very proud of.
We have a number of activities and programs planned
during our meeting to benefit the citizens of New Orleans.
We again held a high-school workshop, with over 200 stu-
dents and teachers in attendance. This included hands-
on experiences in extracting DNA, but from a source I
doubt many of us have experience in—strawberries. Ac-
tually, there are good genetic reasons to choose strawber-
ries. For example, they are octaploid, provide more bang
for the buck, so to speak, relative to DNA isolations. More-
over, DNA is easily isolated from strawberries, as they make
terrific smoothies, or, as we refer to them, “lysates.”
The Society has also coordinated a visit by the Discovery
Genomics Mobile Laboratory from the Venter Institute to
provide laboratory courses for middle- and high-school
students yesterday and today. The mobile lab is parked
outside the entrance to hall F, and I encourage you to visit.
We also held the first-ever workshop for undergraduate
educators. This was attended by over 50 undergraduate
faculty, many from local universities and colleges, but a
few from elsewhere, including Europe. Using an interac-
tive format relating genetics to such social issues as race,
popular media, and genetic testing, this workshop pro-
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vided these educators with the resources to now include
human genetics into their individual curriculum.
Finally, as many of you know, we have established a
fund-raising effort on behalf of the New Orleans school
system. This will help their professional-developmentcen-
ter with training and materials/equipment for genetics
and biotechnology, so that our visit to New Orleans will
have a lasting impact. So far, we have raised almost $9,000
from members, those with the “donor” tag on their name
badges. The ASHG is matching this donation dollar for
dollar, up to $20,000. If you have not done so, it is not
too late to donate to this worthy cause at booth #1018 or
at the cybercafe´.
Thanks to the ASHG staff, particularly Kenna Shaw and
the Information and Education Committee, for providing
the leadership on these important efforts. Now on to the
remainder of the address.
The Member in Society
As investigators and practitioners of human genetics, it is
easy to become so engrossed in our daily work that we
occasionally risk losing sight of all the external influences
that affect our professional lives. Social, governmental,
and educational policies are evolving, and the dynamics
are often driven by the most influential but not necessarily
the most well informed. Governmental actions can affect
how we practice our craft, how we fund our research, in-
deed can legislatively and criminally ban aspects of our
work, and, in general, limit the scope of our efforts. Often,
the actions taken mirror social opinions that influence
what should or should not be taught in our schools. As
human geneticists, I believe we have a special responsi-
bility to be aware of and participate in the dialogue sur-
rounding these issues. It is critical that we help our public
and elected officials understand the impact of our work
on human health. We do good work, and they need to
know this.
This past spring, the ASHG Board of Directors met in
Washington, D. C., for our spring board meeting. We set
aside a day to go to the Hill and meet with members of
Congress and their staff regarding genetic nondiscrimina-
tion legislation, as well as NIH funding. Although Otto
von Bismarck commented many years ago that “Laws are
like sausages. It is better not to see either being made,”
the visit was fascinating and, more importantly, success-
ful, as I think our message was heard and appreciated by
the legislative offices. I encourage you all to get involved
in these advocacy efforts. Meet with your local represen-
tative, either at the home office or when you visit the
D. C. area. Invite your elected officials to your laboratory
to learn about the important work you do and to see first
hand that NIH funding goes well beyond Bethesda. A com-
mon misconception on the Hill is that the NIH appropri-
ation is largely for the Bethesda campus. Point out how
many people are employed in your group, your university,
or hospital and how important NIH funding is to maintain
an active effort. Explain to them how rapid the advances
are in human genetics and how important the genome
effort was for our field and most other disciplines. But also
explain that the translation of basic science breakthoughs
to the clinic and population takes time. However, great
strides have been made against a large number of disorders
since the doubling of the NIH budget, and we are poised
on the cusp of truly revolutionary advances made possible
by genetic studies. We must not slow this effort, and we
need to let our representatives know this. Many univer-
sities have legislative offices; find out if your institution
does and ask them to help. But really, simply picking up
the phone or writing a letter to your local representative,
inviting him or her to visit, can begin a dialogue.
Such efforts are particularly important today, as human
genetics is certainly on the radar screen in the legislative
offices. There are important issues currently under debate
that could substantially impact your work. The Genetic
Nondiscrimination Act has passed unanimously in the
Senate and now has 246 sponsors in the House and hope-
fully will pass soon or, probably more likely, in the new
Congress. This act ensures that an individual’s private,
personal genetic information cannot be used against him
or her. For example, employers cannot fire someone be-
cause he or she is more likely to develop a genetic disorder.
Nor can they require employees to undergo genetic test-
ing. Under this bill, health insurance companies cannot
deny coverage or charge a higher premium to a healthy
individual solely on the basis of genetic disposition to a
disease or a disorder. Another issue to pay attention to is
the NIH Reauthorization Reform Act. While this appears
to be a good thing at first glance, it includes language to
establish what is called an “NIH Common Fund,” where
a substantial amount of the NIH budget, half of all new
funding up to 5% or more, would not flow through the
institutes but rather would remain under the control of
the director. While it remains to be seen how well this
will work, it is a significant departure from the way NIH
funds are normally disbursed. This could potentially be a
good change for our field, with, for example, these funds
being used for multi-institute, multidisciplinary efforts
that are particularly large scale and expensive. It is im-
portant, however, that these funds be used for the best
science possible. At a time of diminished NIH funding, it
is important that every dollar is used wisely.
Senator Barack Obama recently introduced the Genomics
and Personalized Medicine Act in the Senate, which would
substantially increase congressional awareness of the prom-
ise and power of human genetics. It is still the early days
for this bill, but I think you can appreciate that, at the
federal level, all these bills, and others I do not have time
to mention, impact one way or another what we do. It is
not just the legislature that is interested in human ge-
netics; various regulatory agencies also are considering as-
pects of human genetics. Indeed, in recent months, the
FDA has shown increasing interest in the regulation of
genetic testing that could have a major impact on clinical
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genetics and the translation of research discoveries into
the diagnostic laboratory.
It is therefore imperative that we pay attention to the
legislative process and voice our opinions. When you re-
ceive an e-mail from ASHG (or any other professional so-
cieties you may belong to) regarding an upcoming con-
gressional vote, please be make your opinion known to
your Representative or Senator. It really is not hard. If you
go to the ASHG public-policy Web page, you can find
detailed legislative information and access to the e-mail
addresses of your representatives in the House and Senate.
A simple e-mail does the trick. Remember, we are the ex-
perts, and it is incumbent upon us to educate our political
leaders and help guide them, the best we can, into making
the best decisions possible. Bad decisions are sometimes
like toothpaste—very difficult to get back into the tube
once squeezed.
We should also be good role models in this regard to
our fellows and students. Part of their training should in-
clude the importance of public policy on their future live-
lihood, and participation in policy forums and public ed-
ucation is an important task. I realize, after writing this,
that these comments are very U.S.-centric, and I did not
mean to not include our Canadian colleagues and those
from elsewhere in North America and, indeed, the world.
I believe the general message of participation in the public
discourse regarding human genetics is important in any
country, and I encourage everyone to play a role in height-
ening public awareness of our field.
Indeed, public education is the other cornerstone to en-
hance biomedical research. People fear the unknown, and
I believe some of the mistrust of “genetics research” by
the public is due to both a lack of understanding and
journalistic sensationalism. This mistrust is also not un-
common, even among university and medical-school fac-
ulty. How many of us have had to “jump through hoops”
or otherwise excessively justify our research plans to our
IRBs simply because we will collect DNA? Somehow, draw-
ing a few ccs of blood or, worse yet, a buccal wash, places
our research into a category evoking high anxiety among
IRB members, right along with highly invasive and risky
surgical protocols, simply because we wish to genotype.
While there most certainly are special circumstances in-
volved with genetic studies that I do not wish to minimize,
often the concern is beyond the reality. The problem, I
am convinced, is a pervasive lack of understanding of ge-
netics and the actual risks associated with genetic infor-
mation, as opposed to the perceived risks often garnered
from the popular media, as opposed to competent scien-
tific evaluation of risk. Education is the key. We need to
educate members of the IRB and provide a voice at the
table. We must make IRB service, an often time-consum-
ing, little-rewarded effort, an important service contribu-
tion for human geneticists. We have also found placing
genetic counselors on IRBs to be particularly effective,
since they are skilled at explaining genetics to the naive,
which, unfortunately, is sometimes the situation on such
boards. When we teach medical students and residents,
we should include a balanced and realistic discussion of
genetic risks. These are the future IRB members, and it is
our obligation to educate them on ethical issues related
to genetics research on humans.
While we are fortunate that human genetics enjoys a
certain level of popular interest, with television programs
like CSI and such, however, again, I am surprised how
little the general population knows about what we do.
Despite the Genome Project’s massive press coverage mak-
ing most folks aware of DNA and even genomics, the
depth of understanding is rather shallow. This has led to
a general suspicion, at times, regarding what we do. In-
deed, one of the underlying reasons for the Genetic Non-
discrimination Act was simply to alleviate largely unsub-
stantiated fears of genetic testing. It is a real concern that,
if people are fearful of the consequences of genetic testing,
they will avoid it and therefore not realize the full poten-
tial, over the coming years, of advances in testing for ge-
netic predisposition to disease. The popular press, in many
cases, has emphasized the sometimes real and often imag-
ined dangers of genetic research. What can we do? Write
op-ed pieces for your local newspaper, call in to local talk-
radio shows, and be available for the local printed and
electronic press. If we shrink away from such issues, it is
our fault and our fault alone. There is no reason to be
defensive or apprehensive about this. First, we are not, in
the words of another president, evil doers. We do good
work for which we should be justifiably proud. Second,
biomedical research has long been regarded by the public
as a highly respected profession. Indeed, the recent, an-
nual Harris poll showed the profession of scientist as the
most respected occupation in the country, edging out fire-
men by 5 points. Every 5 year old should be told this.
We should be a clear and frequent voice in support of
science in general and, in particular, human genetics. The
Society is enhancing its efforts in public education. I am
very pleased to report that ASHG’s expanded educational
efforts, begun by my predecessors, is paying off in a big
way. Kenna Shaw recently received word that her NSF pro-
posal to establish the Genetics Educator Network of Alli-
ances (GENA) will be funded. This award, in excess of $1
million, will fund a partnership among ASHG, the Genet-
ics Society of America, the National Science Resources
Center, and the National Association of Biology Teachers,
to develop a network of geneticist mentors partnered with
high-school biology teachers. With the nationwide cadre
of 92 such high-school teachers, a minimum of 15,000
students are expected to be reached. Moreover, this pro-
gram will vastly improve science-education outreach by
genetics faculty at all levels of career development. Among
many other aims, GENA will also make it much easier for
us to do community outreach, by providing content-spe-
cific support. So, in this coming year, I ask each and every
one of you to do something for the betterment of our field
at a societal level. We can make a difference if everyone
put in even a small effort.
Finally, not all efforts should be external to the ASHG.
We need more involvement in our Society by its members.
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Participation is essential to the growth, vibrancy, and suc-
cess of this organization. Please play a role in the direction
that ASHG takes and let your voice be heard regarding how
our Society can better serve its members. For example, seek
nomination to one of the ASHG committees. Send you
name to the Society office or any of the board members,
indicating your willingness to serve. Nominations, partic-
ularly of early career scientists, are needed also. We need
to broaden our reach and need fresh viewpoints to make
this happen.
Please attend this year’s business meeting on Thursday
at 2:30 P.M., here in hall F. Only through engagement of
the membership can we really be a strong and positive
force influencing the many aspects of the future of human
genetics.
I began this address by saying I was proud to stand be-
fore you as president of the American Society of Human
Genetics. I am more proud simply to be a human genet-
icist. It is, without a doubt in my mind, the best job in
the world. Being a scientist is great, being a human ge-
neticist is better. We are part of a most remarkable field.
Human genetics research is one of the broadest areas of
science I can imagine. Everything from anthropology, evo-
lution, and human history to mathematics to clinical ge-
netics to public health is included. If we simply look at
our membership applications under the interest query, we
see a myriad of topics. Cancer genetics, cytogenetics, DNA
forensics, ethics, biochemical genetics, molecular genet-
ics, epidemiology, genomics, model systems; the list goes
on and on. We are the ultimate translational field that,
throughout its history, has bridged between the basic sci-
ences and the clinical sciences. We collectively move from
populations to molecules to mathematic theory with ease.
The American Society of Human Genetics brings us all
together. It is the a remarkable collection of people from
all over the world who come together annually at our
meeting that is special. It makes this Society our home.
This I want to emphasis to all the trainees and students
in the audience. In my estimation, one ingredient of hav-
ing a successful scientific career is to have a solid long-
term scientific home. I came to this meeting the first time
in 1975. I was still an undergraduate, relegating me to ride
behind the back seat in Tom Glover’s Pinto, all the way
from East Lansing to Baltimore. At that meeting, I saw all
the giants of the field, many of whom are still with us at
this meeting. I knew I had found a home. When I now
look at colleagues in different disciplines, I know how
lucky I am that I found this scientific home. Of course,
the Society was a lot smaller back then and the meetings
more easily navigated. With our success as a field, some
mixed blessings have occurred. The annual meeting is
quite a bit larger, for example. This makes it somewhat
more difficult for the younger members to network and
meet each other. I want them to meet their peers and begin
viewing this annual meeting as a means to reconnect with
old friends and meet new ones. Accordingly, this year, we
established an ad hoc postdoctoral committee to develop
meeting content specifically for those in training. Tonight,
nearly 300 students and postdoctoral fellows will gather
for a program designed to illustrate the many career paths
available to them. Besides the traditional academic and
corporate PI route, other options, such as laboratory diag-
nostics, scientific publishing, science policy, and intellec-
tual and patent law, will be discussed. The attendees will
be able to make contact with and network with the speak-
ers, who have all agreed to be a contact point for further
investigation of careers. Finally and equally important,
they will gather informally over refreshments to meet each
other and make new and hopefully lifelong friends in this
field. This will keep them coming back, as I have year after
year. We shouldn’t forget, however, other long-standing
aspects of our meeting that are particularly good for train-
ees. This meeting is one of the only meetings of a large
professional scientific society where trainees often deliver
platform presentations. This has been a unique aspect of
our meeting. In many other areas, the annual meeting
largely, if not exclusively, comprises invited talks by lead-
ing authorities. Senior members, let alone trainees, are
happy for their abstract to be chosen for a poster presen-
tation. Here, trainees often compose a large fraction of our
platform presentations as well as our poster sessions. We
should make this very positive aspect of our meeting
known to trainees at our institutions who might be doing
work that would fit well within our meeting.
Few societies have the social fabric of this meeting. If I
am honest with myself, it really isn’t the science alone
that draws me every year to this meeting. To be sure, there
is plenty of terrific science here, and the program com-
mittee works very hard to put together a vibrant and in-
tellectually stimulating meeting. That is the draw. But
there are also quite a few other meetings with outstanding
science. It is not, however, the same. I enjoy those meet-
ings, but I come every year to this meeting to see all those
friends I have made in the human genetics community
since 1975. To me, it is that interaction that is priceless.
Yes, this meeting involves science—but not necessarily
limited to the talks or posters. It is a meeting that virtually
everybody in the human genetics community attends.
Collaborations are established, data and insight are infor-
mally shared, potential postdocs or faculty are met, and,
yes, a good time is had by all. This year, we have limited
some of the evening sessions, not only to take advantage
of New Orleans, but also to allow time to reconnect with
your friends. The social interactions are absolutely a key
piece of doing outstanding science, and going out to din-
ner with colleagues or meeting them over a drink is as
important a part of this meeting as are the talks and poster.
Victor McKusick began his presidential address 14 years
ago with the words “Science is a social enterprise.” I will
end mine with the same sentiment. This meeting, this
Society, is the fabric of our field. So enjoy each other, enjoy
the city, and laissez les bons temps rouler!! Thank you.
